tradingkey.logo
搜索
市场行情
自选
新闻
分析
交易工具
选股器
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
tradingkey.logo
搜索

Charles River Laboratories International Inc

CRL
添加自选
234.800USD
-5.630-2.34%
收盘 07-29 16:00（美东）报价延迟15分钟
11.31B总市值
亏损市盈率 TTM

Charles River Laboratories International Inc

234.800
-5.630-2.34%
概览
财务
分析
公司
财务摘要利润表资产负债表现金流量表

概览

财务

分析

公司

财务摘要利润表资产负债表现金流量表

CRL 财务数据

通过专为投资者打造的一站式数据看板，全面查看 Charles River Laboratories International Inc 的财务状况。平台将复杂的财务报表整理为可自定义的视图，助您更轻松地进行财务分析。您可以查看最新年度财务报告，也可以通过利润表、资产负债表和现金流量表，按季度分析公司表现。借助实时财务指标，持续追踪公司的经营状况和市场表现更加便捷。

Charles River Laboratories International Inc财报日历

最新发布
8月 5, 2026
每股收益 / 预测值
--/2.73
营业收入 / 预测值
--/974.72M
查看即将公布的财报 >>
报告期
FY2025 财报
营业收入(YoY)
4.02B
-0.85%
每股收益(YoY)
-2.91
-1553.10%
分析师评级
BUY
2026/07/29
单季报
单季报+年报
单季报
年报
YOY
隐藏空白行
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
财务指标
每股收益
-160.33%-0.30
-33.22%-5.62
-17.25%1.11
-39.01%1.06
-61.60%0.50
-215.69%-4.22
-21.58%1.34
-7.85%1.75
-35.15%1.31
-0.95%3.65
--1.70
--1.89
--2.02
--3.68
--5.88
----
----
----
----
----
营业收入
1.18%995.83M
-0.83%994.23M
-0.49%1.00B
0.59%1.03B
-2.71%984.17M
-1.08%1.00B
-1.64%1.01B
-3.19%1.03B
-1.73%1.01B
-7.85%1.01B
3.79%1.03B
8.92%1.06B
12.63%1.03B
21.52%1.10B
10.40%989.16M
6.40%973.13M
10.84%913.93M
14.42%905.05M
20.54%895.94M
33.99%914.61M
净利润
-158.28%-14.84M
-28.21%-276.56M
-20.76%54.42M
-41.85%52.33M
-62.17%25.47M
-215.30%-215.70M
-21.41%68.68M
-7.25%89.99M
-34.72%67.33M
-0.17%187.08M
-9.42%87.39M
-11.25%97.02M
10.87%103.13M
36.22%187.41M
-6.72%96.47M
23.60%109.32M
51.18%93.02M
-3.92%137.58M
0.50%103.43M
31.16%88.45M
利润率
-156.53%-1.49%
-30.34%-27.79%
-20.58%5.53%
-44.42%5.11%
-64.29%2.63%
-214.36%-21.32%
-18.80%6.96%
-2.09%9.19%
-27.09%7.36%
8.43%18.64%
--8.57%
--9.38%
--10.10%
--17.19%
--10.55%
----
----
----
----
----
毛利率
10.64%30.90%
11.48%30.96%
-2.70%32.32%
-5.71%30.83%
-11.78%27.93%
-16.41%27.77%
-0.26%33.21%
-4.99%32.69%
-4.93%31.65%
0.54%33.23%
--33.30%
--34.41%
--33.30%
--33.05%
--33.12%
----
----
----
----
----
资产负债率
4.22%34.56%
0.64%29.99%
0.04%29.12%
1.76%30.89%
1.51%33.16%
-7.95%29.80%
-12.02%29.11%
-12.04%30.35%
-8.57%32.66%
-9.23%32.37%
--33.09%
--34.51%
--35.72%
--35.66%
--39.81%
----
----
----
----
----
利润表
营业收入
1.18%995.83M
-0.83%994.23M
-0.49%1.00B
0.59%1.03B
-2.71%984.17M
-1.08%1.00B
-1.64%1.01B
-3.19%1.03B
-1.73%1.01B
-7.85%1.01B
3.79%1.03B
8.92%1.06B
12.63%1.03B
21.52%1.10B
10.40%989.16M
6.40%973.13M
10.84%913.93M
14.42%905.05M
20.54%895.94M
33.99%914.61M
营业利润
53.76%151.48M
33.28%120.22M
2.05%151.08M
-21.98%132.33M
-31.10%98.51M
-39.99%90.20M
-11.72%148.05M
2.07%169.61M
-15.38%142.98M
-8.24%150.31M
11.08%167.70M
-11.33%166.17M
13.56%168.96M
-9.96%163.81M
-7.94%150.98M
21.64%187.41M
11.79%148.78M
31.29%181.93M
22.82%164.00M
88.14%154.07M
净利润
-158.28%-14.84M
-28.21%-276.56M
-20.76%54.42M
-41.85%52.33M
-62.17%25.47M
-215.30%-215.70M
-21.41%68.68M
-7.25%89.99M
-34.72%67.33M
-0.17%187.08M
-9.42%87.39M
-11.25%97.02M
10.87%103.13M
36.22%187.41M
-6.72%96.47M
23.60%109.32M
51.18%93.02M
-3.92%137.58M
0.50%103.43M
31.16%88.45M
资产负债表
流动资产
-1.17%1.49B
3.13%1.45B
2.50%1.53B
-1.96%1.47B
-9.70%1.51B
-12.78%1.40B
3.49%1.49B
-0.37%1.50B
15.18%1.67B
11.79%1.61B
2.05%1.44B
8.02%1.50B
8.65%1.45B
12.95%1.44B
2.63%1.42B
9.87%1.39B
-6.33%1.33B
6.07%1.27B
20.94%1.38B
2.69%1.27B
流动负债总额
4.06%1.09B
12.70%1.12B
10.83%1.12B
14.03%1.08B
10.08%1.05B
-5.78%994.10M
1.85%1.01B
-5.96%947.52M
-2.71%954.81M
-3.34%1.06B
-2.01%993.82M
-3.87%1.01B
-1.25%981.39M
5.65%1.09B
3.09%1.01B
12.75%1.05B
23.71%993.84M
23.03%1.03B
25.00%983.75M
27.70%929.61M
总资产
1.95%7.73B
-5.22%7.14B
-6.12%7.51B
-4.88%7.56B
-7.00%7.58B
-8.13%7.53B
5.22%8.00B
2.26%7.95B
5.89%8.15B
7.79%8.20B
3.04%7.61B
3.23%7.77B
8.83%7.70B
8.24%7.60B
4.59%7.38B
12.04%7.53B
21.80%7.08B
27.93%7.02B
35.39%7.06B
28.23%6.72B
总负债
9.25%4.74B
-2.39%3.92B
-2.71%4.06B
-0.34%4.16B
-2.43%4.34B
-11.37%4.02B
-1.88%4.18B
-6.65%4.18B
-2.06%4.45B
-0.94%4.54B
-9.65%4.26B
-7.52%4.47B
3.14%4.54B
3.32%4.58B
2.55%4.71B
10.76%4.84B
22.59%4.40B
32.42%4.43B
39.72%4.59B
26.18%4.37B
总权益
-7.82%2.99B
-8.46%3.21B
-9.85%3.45B
-9.90%3.40B
-12.48%3.24B
-4.12%3.51B
14.24%3.83B
14.34%3.77B
17.33%3.70B
21.02%3.66B
25.40%3.35B
22.54%3.30B
18.20%3.16B
16.65%3.02B
8.41%2.67B
14.40%2.69B
20.51%2.67B
20.91%2.59B
28.00%2.46B
32.21%2.35B
现金流量表
经营净额
-76.08%41.08M
-7.43%147.52M
-15.08%213.83M
5.72%204.60M
32.19%171.70M
-27.87%159.36M
22.56%251.79M
30.66%193.53M
18.75%129.89M
-5.88%220.94M
54.73%205.45M
-0.90%148.12M
6.58%109.38M
2.40%234.76M
-24.01%132.78M
-19.89%149.47M
-39.71%102.63M
65.67%229.26M
-1.45%174.72M
14.96%186.59M
投资净额
-796.78%-407.85M
-21.95%-92.81M
-58.02%-33.70M
39.65%-37.34M
46.99%-45.48M
68.07%-76.10M
73.20%-21.32M
19.24%-61.87M
49.12%-85.79M
-637.08%-238.37M
13.70%-79.56M
83.42%-76.61M
-72.05%-168.62M
376.88%44.38M
74.04%-92.19M
51.57%-462.11M
28.98%-98.00M
110.53%9.31M
-401.41%-355.05M
-3233.31%-954.19M
融资净额
430.14%347.72M
31.65%-51.86M
26.46%-152.62M
20.62%-226.92M
-674.10%-105.33M
-161.41%-75.88M
-27.43%-207.54M
-300.00%-285.86M
-27.32%18.35M
149.63%123.57M
-215.67%-162.87M
-126.33%-71.46M
290.02%25.24M
-13.69%-248.96M
-128.84%-51.59M
-47.59%271.44M
-106.82%-13.28M
-269.70%-218.97M
166.59%178.90M
597.57%517.96M

常见问题

Charles River Laboratories International Inc的总收入是多少？

根据Charles River Laboratories International Inc的FY2025财报，总收入达到了4.02B（同比变化4.05B）。

Charles River Laboratories International Inc的流动资产是多少？

根据Charles River Laboratories International Inc的FY2025财报，流动资产为1.45B（同比变化3.13）。

Charles River Laboratories International Inc的总资产是多少？

根据Charles River Laboratories International Inc的FY2025财报，Charles River Laboratories International Inc的总资产为7.14B（同比变化-5.22）。

Charles River Laboratories International Inc的总负债是多少？

根据Charles River Laboratories International Inc的FY2025财报，Charles River Laboratories International Inc的总负债为3.92B（同比变化-2.39）。

Charles River Laboratories International Inc的总权益是多少？

根据Charles River Laboratories International Inc的FY2025财报，Charles River Laboratories International Inc的总权益为3.21B（同比变化-8.46）。

Charles River Laboratories International Inc的净营业收入是多少？

根据Charles River Laboratories International Inc的FY2025财报，Charles River Laboratories International Inc的净营业收入为502.15M（同比变化-8.84）。

Charles River Laboratories International Inc的净投资是多少？

根据Charles River Laboratories International Inc的FY2025财报，Charles River Laboratories International Inc的净投资为-191.88M（同比变化21.71）。

Charles River Laboratories International Inc的净融资是多少？

根据Charles River Laboratories International Inc的FY2025财报，Charles River Laboratories International Inc的净融资为-536.73M（同比变化2.58）。

Charles River Laboratories International Inc的每股收益（EPS）是多少？

根据Charles River Laboratories International Inc的FY2025财报，每股收益（EPS）为-2.91（同比变化-1553.10）。

Charles River Laboratories International Inc的净利润是多少？

根据Charles River Laboratories International Inc的FY2025财报，净利润为-144.34M（同比变化-1501.75）。

Charles River Laboratories International Inc的净利润率是多少？

根据Charles River Laboratories International Inc的FY2025财报，净利润率为-3.54（同比变化-666.95）。

Charles River Laboratories International Inc的毛利率是多少？

根据Charles River Laboratories International Inc的FY2025财报，毛利率为30.52（同比变化-2.63）。

Charles River Laboratories International Inc的债务与资产比率是多少？

根据Charles River Laboratories International Inc的FY2025财报，债务与资产比率为29.99（同比变化0.64）。

Charles River Laboratories International Inc的股东权益回报率（ROE）是多少？

根据Charles River Laboratories International Inc的FY2025财报，股东权益回报率（ROE）为-4.36（同比变化-1593.19）。

Charles River Laboratories International Inc的资产回报率（ROA）是多少？

根据Charles River Laboratories International Inc的FY2025财报，资产回报率（ROA）为-1.94（同比变化-702.73）。

Charles River Laboratories International Inc的营业利润是多少？

根据Charles River Laboratories International Inc的FY2025财报，营业利润为502.15M（同比变化-8.84）。
tradingkey.logo
风险提示：我们的网站和移动应用程序仅提供关于某些投资产品的一般信息。Finsights 不提供财务建议或对任何投资产品的推荐，且提供此类信息不应被解释为 Finsights 提供财务建议或推荐。
投资产品存在重大投资风险，包括可能损失投资的本金，且可能并不适合所有人。投资产品的过去表现并不代表其未来表现。
Finsights 可能允许第三方广告商或关联公司在我们的网站或移动应用程序的任何部分放置或投放广告，并可能根据您与广告的互动情况获得报酬。
© 版权所有: FINSIGHTS MEDIA PTE. LTD. 版权所有
一般使用条款
隐私政策
Cookie政策